Association between an early humoral response to Mycobacterium tuberculosis antigens and later development of tuberculosis in human immunodeficiency virus-infected individuals

International Journal of Tuberculosis and Lung Disease

Volumn 1, Issue 2, 1997, Pages 170-174

  Cavalcante, S ^a   Kritski, A L ^a   Ferreira, M A S ^a   Souza, M A ^a   Laszlo, A ^b   Werneck Barroso, E B ^a   Fonseca, L S ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Natl Ref Centre for Tuberculosis   (Canada)

Author keywords

Early diagnosis; HIV infection; Serodiagnosis; Tuberculosis

Indexed keywords

BACTERIUM ANTIBODY; TUBERCULIN;

ADULT; AIDS RELATED COMPLEX; ANTIBODY PRODUCTION; ARTICLE; BLOOD; CASE CONTROL STUDY; CONFIDENCE INTERVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RISK; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; ODDS RATIO; SENSITIVITY AND SPECIFICITY; TUBERCULIN; TUBERCULOSIS;

EID: 0031107535     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Kochi A The global tuberculosis situation and the new control strategy of the World Health Organization (Editorial). Tubercle 1991; 72: 1-6.
2. Barnes P F, Bloch A B, Davidson P T, Snider Jr D E. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1991; 324: 1444-1650.
3. Chaisson R E, Schecter G F, Goodman P C E, et al. Tuberculosis in patients with acquired immunodeficiency syndrome. Am Rev Respir Dis 1987; 136: 570-574.
4. Hopewell P C. Impact of human immunodeficiency virus infection on the epidemiology, clinical features, management, and control of tuberculosis. Clin Infect Dis 1992; 15: 540-547.
5. Berlie H C, Petit J C, David H L. Use of the SL-IV and PGL-Tb1 glycolipid antigen in ELISA for the diagnosis of tuberculosis in AIDS patients. Zentollb Bakteriol 1991; 275: 351-357.
6. Martin-Casabona N, Gonzalez Fuente T, Papa F, et al. Time course of anti-SL-IV immunoglobulin G antibodies in patients with tuberculosis and tuberculosis-associated AIDS. J Clin Microbiol 1992; 30: 1089-1093.
7. Saad M H F, Kritski A L, Werneck-Barroso E, Cavalcante S, Ferreira M A S, Fonseca L S. Use of the 2,3-diacy-trehalose (SL-IV) and the purified protein derivative (PPD) in the serodiagnosis of tuberculosis in AIDS. Memórias Inst Oswaldo Cruz 1996; 91: 97-100.
8. Laszlo A, Baer H H, Goren M B, Handzel V, Barrera L, Kantor I N. Evaluation of synthetic pseudo cord-factor-like glycolipids for the serodiagnosis of tuberculosis. Res Microbiol 1992; 143: 217-223.
9. van Vooren J P, Farber C M, Motte S, De Bruyn J, Legros F, Yernault J C. Assay of specific antibody response to mycobacterial antigen for the diagnosis of pleural effusion in a patient with AIDS. Tubercle 1988; 69: 303-305.
10. Fonseca L S, Kritski A L, Sant'Anna C C, Janini M C, Ferreira M A S, Saad M H F. Relationship between immune response and clinical manifestation in patients with tuberculosis. Brazilian J Med Biol Res 1992; 25: 49-52.
11. Barrera L, Kantor I, Ritacco V, et al. Humoral response to Mycobacterium tuberculosis in patients with human immunodeficiency virus infection. Tubercle Lung Dis 1992; 73: 187-191.
12. Theuer C P, Chaisson R E, Elias D, et al. Detection of circulating antibodies to purified protein derivative in tuberculosis patients with and without human immunodeficiency virus infection. [Abstract]. Am Rev Respir Dis 1989; 139 (Suppl): A 395.